EVIDENCE-BASED SUPPORT
At Dr. J Medical, Central Hong Kong, our science-based weight management programme utilises evidence-based pharmacological interventions, including GLP-1 and GLP-1/GIP therapies, under the clinical oversight of licensed physicians. Every treatment plan is individually assessed and monitored, ensuring both safety and effectiveness as you work toward sustainable weight loss and improved metabolic health — supporting not just your aesthetic goals, but your long-term wellbeing.
Many clients combine GLP-1 therapy with IV nutritional support and aesthetic treatments to achieve a fully integrated approach to body composition and overall appearance.
Dr. J Medical, Central HK — physician-led weight management using evidence-based GLP-1 & GLP-1/GIP therapies, safely supervised by licensed doctors.
Weight Management —Clinical Protocolsand Medical Supervision
Utilizing evidence-based pharmacological interventions, including GLP-1 and GLP-1/GIP therapies, under the clinical oversight of licensed physicians.
GLP-1 and GLP-1/GIP treatments are prescription-only medications. A formal medical evaluation and physician consultation are mandatory prior to any pharmacological intervention. This content is for information only.
The Obesity Landscape in Hong Kong
Weight management has become a critical health issue in Hong Kong's fast-paced urban environment. Local health data shows approximately 32.6% of adults aged 15–84 meet the clinical threshold for obesity (BMI ≥25), with a further 22% classified as overweight (BMI ≥23–24.9). Nearly 40% of overweight individuals do not accurately recognise their own weight status — underscoring the importance of proper medical assessment over guesswork.
Utilizing evidence-based pharmacological interventions, including GLP-1 and GLP-1/GIP therapies, under the clinical oversight of licensed physicians.
Excess weight is not merely a cosmetic concern. It is a recognised driver of type 2 diabetes, cardiovascular disease, hypertension, obstructive sleep apnea, and certain cancers. Medical weight management addresses both the weight and the underlying metabolic risk.
HOW IT WORKS
01
In-clinic doctor assessment — BMI, medical history, contraindication screening
02
Personalised prescription — Semaglutide or Tirzepatide, based on your health profile
03
Ongoing treatment — regular doctor follow-up and clinical monitoring throughout
04
Online enquiry or consultation booking
Why Mounjaro® (Tirzepatide) May Be Right for You
Tirzepatide is the first dual-receptor agonist targeting both GLP-1 and GIP pathways simultaneously.
-
Stronger blood sugar regulation through complementary insulin-secretion pathways
-
More significant weight reduction in clinical studies compared to GLP-1-only agents
-
Additional metabolic health benefits, including reduced cardiovascular risk factors
-
Suitable for patients with type 2 diabetes seeking both glycaemic control and weight loss
Your doctor will determine which treatment is most appropriate for your individual health profile during consultation.
Who May Be Suitable for This Treatment
-
Adults with a BMI of 30 kg/m² or higher
-
Adults with a BMI of 27–29.9 kg/m² with weight-related conditions (e.g., high blood pressure, abnormal cholesterol, prediabetes, type 2 diabetes, sleep apnea)
-
Adults with type 2 diabetes seeking better glycaemic control alongside weight management
Eligibility is determined by a doctor during your in-clinic consultation. Not all patients will be suitable.
Important Safety Information
GLP-1 and GLP-1/GIP therapies are prescription medications and must be used under a doctor's supervision. Patients must complete an in-clinic consultation, medical history review, and contraindication screening before any medication is prescribed or dispensed.
These treatments are not suitable for patients with a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), pancreatitis, or who are pregnant or breastfeeding.
This information does not constitute medical advice and cannot replace a healthcare professional's clinical judgement.
Frequently asked questions
- 01
- 02
- 03
- 04
- 05
- 06
- 07
- 08